Complement activation by beta-amyloid in Alzheimer disease. - Wikidata - wikimedia - TriplyDB

Complement activation by beta-amyloid in Alzheimer disease.

Complement activation by beta-amyloid in Alzheimer disease.

http://www.wikidata.org/entity/Q37262889

about

Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle Using animal models to determine the significance of complement activation in Alzheimer's disease Novel Abeta peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease.Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases Genetics ignite focus on microglial inflammation in Alzheimer's disease The proteomics of drusen Inflammatory process in Alzheimer's Disease The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex.Microglia communication: Parallels between aging and Alzheimer's disease Inflammation and Alzheimer's disease Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.Transcriptomics of cortical gray matter thickness decline during normal aging The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.Identification and characterisation of C1q-binding phage displayed peptides.The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration.A simple, yet highly accurate, QSAR model captures the complement inhibitory activity of compstatin Can oral infection be a risk factor for Alzheimer's disease?Neuropathology of Alzheimer's disease Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages.Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease Sortilin Fragments Deposit at Senile Plaques in Human Cerebrum Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimer's disease Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation.Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.The role of microglia in human disease: therapeutic tool or target?Anti-inflammatory drugs: a hope for Alzheimer's disease?Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.Identification of a central role for complement in osteoarthritis.Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis Genetic alterations of the BRI2 gene: familial British and Danish dementias.Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease.

P2860

Q24530132-27D54830-BE32-4105-A937-CF6F21C1422D Q24537408-3726419F-6D65-4A40-91FC-DF58D8F3B488 Q24600266-C60E4E65-8424-4DC6-9A00-DB1873E3F128 Q24796236-26B00612-8668-41A0-AEE9-D6D38C127B36 Q25256570-3C0757FC-1B5D-4018-9189-55D9A822BF82 Q26771812-5D09DA02-9599-42C0-B363-CED3FAAFD9BC Q26781865-43B3CD2A-79B3-4997-896E-08C1C86E48EE Q26997523-47C01EBB-0CA6-4B7E-B000-C01593ACA0A5 Q27500412-CE5D62D0-6F92-4A82-9B64-FD9541E8923F Q27637552-B758D25D-1C31-47E6-94F5-86B2549177BB Q28074099-D1FD97E7-209A-4DBC-BB05-A8A9EF6733CE Q28138617-297998AC-053C-4AC1-87FC-A76C2810290B Q30054419-E0A989F7-2EB2-4DDB-A835-D1BD63B0685C Q30492292-D05A4550-087E-4985-A5F9-60A35390BA04 Q30543926-53DA1BBF-4ED5-45C5-8E7F-55EFACD7D203 Q30668465-CCF71737-B338-419C-B0DE-4D091CE723E6 Q32126041-4396B628-DD07-4226-9FB5-FED6CCBB468F Q33220400-324A4ACB-4DC7-4457-8A23-937BD54B4D63 Q33264215-BA219ED7-51B9-462B-867F-87D1A93CD0C4 Q33267607-1BE6F5B0-71F5-4BF1-8263-27B2854E7F72 Q33361553-0DA9FFE0-A4E4-4E47-84F3-6A5F2FE05EE5 Q33526568-5F430521-3BE6-48C5-8FF1-470EECEFD444 Q33722131-5589F6F4-2323-4F1A-8FC0-92D4B25F7B8A Q33769083-1162D3BD-C12B-4F91-832B-21B43758EA2B Q33770251-45315F11-0252-4292-881D-1144DDC14145 Q33772181-D6B10D8F-D926-4966-8FD3-73B20722853C Q33773936-F047E059-297F-4869-B8E0-1158661CB289 Q33793485-B540D272-F375-46F1-87E1-DAA43A41F548 Q33888339-4E126585-66F0-47A3-A9CC-893E8C0EBC93 Q33904501-D0FB3E78-18CA-4764-9A5A-18DC0134E85E Q34038205-3428E334-522C-4B33-98C4-E307E2E1EDEF Q34074779-83F5DCBF-413B-4B91-B0F6-15B81822BD7E Q34076162-8ACB118A-A0ED-4ED4-9689-66CD9E8E559F Q34123651-685C62B0-24EF-421E-8068-87DC669CB4DB Q34154466-3980E8D9-A767-4475-95BC-3B35C853D2DD Q34230334-1B0A7726-59EF-47E4-BF63-E2682AC76499 Q34309544-B06A08BE-1A38-4466-8F2C-05BED9E3A77D Q34471200-42E3BF5D-A28D-43F0-BD00-93D2D19E0D24 Q34513577-FEDC95A3-0E23-4F71-9B2A-7A8CD6CAC914 Q34550347-4ADB9037-61FA-4CD4-852E-4BADE95591D1

P2860

Complement activation by beta-amyloid in Alzheimer disease.

http://www.wikidata.org/entity/Q37262889

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年学术文章

@wuu

1992年学术文章

@zh-cn

1992年学术文章

@zh-hans

1992年学术文章

@zh-my

1992年学术文章

@zh-sg

1992年學術文章

@yue

1992年學術文章

@zh

1992年學術文章

@zh-hant

name

Complement activation by beta-amyloid in Alzheimer disease.

@en

Complement activation by beta-amyloid in Alzheimer disease.

@nl

type

label

Complement activation by beta-amyloid in Alzheimer disease.

@en

Complement activation by beta-amyloid in Alzheimer disease.

@nl

prefLabel

Complement activation by beta-amyloid in Alzheimer disease.

@en

Complement activation by beta-amyloid in Alzheimer disease.

@nl

P1433

Q37262889-4D4BADB1-10F4-4DF4-A261-074F05720FE6

P1476

Q37262889-DEDA46DB-B461-43F4-A9CE-6F5C49BE8768

P2093

Q37262889-04732E7B-186A-4112-BD63-F32731933554

Q37262889-54C777A9-CA38-487B-8AE7-5DEC3098B7DA

Q37262889-611DE0CC-4303-4976-86A4-3AB2AD198B5D

Q37262889-62DE5F80-32BA-44B9-B11C-6D940A1FFCE2

Q37262889-7249C328-EA60-42B4-9E44-F735BC9EAC2A

Q37262889-7D95C262-42C7-48A5-801A-5C31934CF08B

Q37262889-8D4B8CBF-6929-4FCD-98A0-8F1950FF6B2E

Q37262889-98F2AF2F-B744-4B41-9F39-6A5ADE7E41C0

Q37262889-C7281257-E629-4575-9074-9C7B16DAE17C

Q37262889-FE14682D-4002-4526-BA10-78EF06456D55

P2860

Q37262889-046F9BF1-18BD-4B23-A9DD-556FD32752AB

Q37262889-15C776A6-F178-4CF2-B7FC-623E9F0B6177

Q37262889-1DF69896-D230-4766-8326-0B44D43C5F9B

Q37262889-3649BB39-ED40-4AFC-94F9-CF822D84D1C6

Q37262889-3F3B530F-C211-46C8-888A-1C6C069D31C7

Q37262889-3F70DD7B-39FA-4F6D-B693-C9C194E08D02

Q37262889-4AF0E277-6FA8-4107-BFAA-BF8D86A9E6C0

Q37262889-53D80D36-A616-497C-BE29-F0D26B299DC8

Q37262889-5B653991-8DD0-48A5-AA28-2C22CED2B2DC

Q37262889-64A50D96-77DF-4648-B1B8-A1FEEAE8A080

P304

Q37262889-8610935B-796A-4848-9D44-55AF7C44C072

P31

Q37262889-0E4098D8-0DC5-4C66-80BD-D7B4C57F993C

P356

Q37262889-DF31C64F-0DB0-4A96-A70E-50F1AD787691

P407

Q37262889-5D1B5A78-79EA-4EFD-95A3-4A1ECF07A0AD

P433

Q37262889-C0F8CD1D-2931-427D-AC37-948AD372D5EC

P478

Q37262889-2E136C02-F32D-4F8B-B980-9299BFBE71D7

P577

Q37262889-03365A2E-76BB-4E3C-8710-A92AED569BEF

P5875

Q37262889-9E9C98AA-935A-46EF-A916-0D11AD37774F

P698

Q37262889-F9C40E12-E1C9-41C2-B02B-92B797FCFCCF

P921

Q37262889-FE3BD44B-77CC-424F-8CA6-01274BC6BBC3

P932

Q37262889-75821B3B-835D-4B53-824A-B0B08F3A0CAA

P356

PNAS.89.21.10016

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Complement activation by beta-amyloid in Alzheimer disease.

@en

P2093

Brachova L

http://www.w3.org/2001/XMLSchema#string

Bradt B

http://www.w3.org/2001/XMLSchema#string

Civin WH

http://www.w3.org/2001/XMLSchema#string

Cooper NR

http://www.w3.org/2001/XMLSchema#string

McGeer PL

http://www.w3.org/2001/XMLSchema#string

Rogers J

http://www.w3.org/2001/XMLSchema#string

Schultz J

http://www.w3.org/2001/XMLSchema#string

Styren SD

http://www.w3.org/2001/XMLSchema#string

Ward P

http://www.w3.org/2001/XMLSchema#string

Webster S

http://www.w3.org/2001/XMLSchema#string

P2860

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

Evidence for a membrane defect in Alzheimer disease brain

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat.

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue.

Autoantibodies to neurofibrillary tangles and brain tissue in Alzheimer's disease. Establishment of Epstein-Barr virus-transformed antibody-producing cell lines.

P304

10016-10020

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.89.21.10016

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

1992-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21717909

http://www.w3.org/2001/XMLSchema#string

P698

1438191

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

50268

http://www.w3.org/2001/XMLSchema#string